These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 8144866

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
    Sartorio A, Conti A, Monzani M.
    Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A, Conte G, Conti A, Masala A, Alagna S, Rovasio P, Faglia G.
    J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of 12 months rhGH treatment on bone and collagen turnover in children with constitutional growth delay.
    Sartorio A, Conti A, Ferrero S, Saraifoger S, Resnik M, Baroncelli GI.
    J Pediatr Endocrinol Metab; 1999 Jun; 12(6):833-8. PubMed ID: 10614540
    [Abstract] [Full Text] [Related]

  • 8. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.
    Conti A, Sartorio A, Ferrero S, Ferrario S, Ambrosi B.
    J Endocrinol Invest; 1996 Feb; 19(2):127-30. PubMed ID: 8778165
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma.
    Sartorio A, Conti A, Ferrero S, Giambona S, Re T, Passini E, Ambrosi B.
    Eur J Endocrinol; 1998 Feb; 138(2):146-52. PubMed ID: 9506857
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.
    Piovesan A, Terzolo M, Reimondo G, Pia A, Codegone A, Osella G, Boccuzzi A, Paccotti P, Angeli A.
    Horm Metab Res; 1994 May; 26(5):234-7. PubMed ID: 8076906
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency.
    Wollmann HA, Schönau E, Blum WF, Meyer F, Kruse K, Ranke MB.
    Horm Res; 1995 May; 43(6):249-56. PubMed ID: 7541769
    [Abstract] [Full Text] [Related]

  • 18. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S, Di Rella F, Pivonello R, Di Somma C, Klain M, Maurelli L, Scarpa R, Colao A, Merola B, Lombardi G.
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [Abstract] [Full Text] [Related]

  • 19. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF.
    J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.